Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03772288
Title A Study of TAK-659 in Combination With NKTR-214 in Participants With Advanced Non-Hodgkin Lymphoma (NHL)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
New York University Langone Medical Center New York New York 10016 United States Details
Alberta Health Services Calgary Alberta T2N 2T9 Canada Details
Jewish General Hospital Montreal Quebec H3T1E2 Canada Details
Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de lEstrie - CHUS) Sherbrooke Quebec J1H 5N3 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field